Who owns the REMASTER trademark?

The REMASTER trademark is owned by Remix Therapeutics Inc..

What is the serial number for REMASTER?

The USPTO serial number for REMASTER is 90552860.

What is the registration number for REMASTER?

REMASTER is registered under USPTO registration number 0.

REM

USPTO Trademark Record

ABANDONED

REMASTER

Q: What class is the REMASTER trademark registered in?

The REMASTER trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 90552860·Reg 0·Filed Mar 01, 2021

Owner Remix Therapeutics Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

REMASTER (Serial No. 90552860), Registration No. 0, is a abandoned US trademark filed on Mar 01, 2021 by Remix Therapeutics Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

REMASTER (Reg. #0) is an abandoned US trademark that was filed in 2021 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 01, 2021

SERIAL

90552860

REG#

Owner

Applicant

Remix Therapeutics Inc.

Entity

Corporation

State

Address

400 Technology Square, Cambridge, MA, 02139

Country

Attorney

NameChristina M. Licursi

Law firm

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

Docket

R08262000200

Address

600 ATLANTIC AVENUE, BOSTON, MA 02210, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 01, 2021

Serial Number90552860

Registration No.0

Status DateOct 07, 2025

Published for OppositionNov 09, 2021

Mark TypeStandard characters

Attorney DocketR08262000200

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

ABANDONMENT - NO USE STATEMENT FILED

Oct 07, 2025

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 07, 2025

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

SOU TEAS EXTENSION RECEIVED

Jul 02, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Jul 02, 2024

SOU EXTENSION 5 FILED

SOU EXTENSION 5 GRANTED

Jul 02, 2024

SOU EXTENSION 5 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 02, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 06, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 04, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Jan 04, 2024

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Jan 04, 2024

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 30, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jun 28, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Jun 28, 2023

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Jun 28, 2023

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 30, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 28, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Dec 28, 2022

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Dec 28, 2022

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 12, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 10, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 10, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 10, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 04, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Nov 09, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 09, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 20, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 01, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 30, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 30, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Sep 29, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 24, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Sep 23, 2021

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

Sep 23, 2021

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Sep 23, 2021

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Sep 23, 2021

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 22, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 30, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

REM

REMASTER

98941335

Remix Therapeutics, Inc.

PENDING

REMASTER

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Remix Therapeutics Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Christina M. Licursi

Resources

Company